Review: taking Coumadin and Hydroxyzine pamoate together


Summary

Drug interactions are reported among people who take Coumadin and Hydroxyzine pamoate together. This review analyzes the effectiveness and drug interactions between Coumadin and Hydroxyzine pamoate. It is created by eHealthMe based on reports of 419 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Coumadin and Hydroxyzine pamoate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Coumadin

Coumadin has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Coumadin 73,237 users)

Hydroxyzine Pamoate

Hydroxyzine pamoate has active ingredients of hydroxyzine pamoate. It is often used in stress and anxiety. (latest outcomes from Hydroxyzine pamoate 988 users)

On Jul, 28, 2016

419 people who take Coumadin, Hydroxyzine Pamoate are studied.


Number of reports submitted per year:

Coumadin and Hydroxyzine pamoate drug interactions.

Drug effectiveness over time:

Coumadin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 50.0% - (1 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Hydroxyzine Pamoate:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Coumadin:
  • female: 0.0% - (0 of 1 people)
  • male: 50.0% - (2 of 4 people)
Hydroxyzine Pamoate:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Coumadin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 50.0% - (1 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (1 of 2 people)
Hydroxyzine Pamoate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • epistaxis
  • international normalised ratio increased
  • orthostatic hypotension
  • blood pressure decreased
  • bradycardia
  • cardio-respiratory arrest
  • convulsion
  • loss of consciousness
  • mouth haemorrhage
  • oxygen saturation decreased
1 - 6 months:
  • international normalised ratio decreased
  • palpitations
  • transient ischaemic attack
  • blood disorder
  • blood immunoglobulin g decreased
  • bundle branch block left
  • chest pain
  • dehydration
  • ear infection fungal
  • erythema
1 - 2 years:
  • death
  • spinal osteoarthritis
2 - 5 years:
  • chest pain
  • convulsion
  • gait disturbance
  • hypertension
  • ligament sprain
  • meniscus lesion
  • neuropathy peripheral
  • rash
  • rhinitis
  • skin disorder
not specified:
  • dyspnoea
  • pain
  • nausea
  • fatigue
  • anxiety
  • weight decreased
  • thrombocytopenia
  • anaemia
  • cardiac failure congestive
  • atrial fibrillation

Most common drug interactions by gender *:

female:
  • fatigue
  • anxiety
  • pain
  • hypertension
  • atrial fibrillation
  • dyspnoea
  • chest pain
  • oedema peripheral
  • nausea
  • injury
male:
  • dyspnoea
  • pain
  • nausea
  • thrombocytopenia
  • weight decreased
  • hyperlipidaemia
  • anxiety
  • anaemia
  • haemorrhage
  • cardiac failure congestive

Most common drug interactions by age *:

2-9:
  • nephritic syndrome
  • glomerulonephritis membranous
  • nephrotic syndrome
  • disease recurrence
  • mucopolysaccharidosis
  • mucopolysaccharidosis vi
  • antibody test abnormal
  • disease progression
  • drug resistance
  • hepatomegaly
20-29:
  • dizziness
  • headache
  • myocardial infarction
  • nausea
  • death
  • thrombosis
30-39:
  • myocardial infarction
  • blood pressure increased
  • crepitations
  • ejection fraction abnormal
  • electrocardiogram qt prolonged
  • oxygen saturation decreased
  • vasospasm
  • weight decreased
  • acute respiratory failure
  • anaemia
40-49:
  • nausea
  • fatigue
  • depression
  • dyspnoea
  • pain
  • multiple myeloma
  • thrombocytopenia
  • pyrexia
  • type 2 diabetes mellitus
  • neutropenia
50-59:
  • pain
  • renal failure acute
  • cellulitis
  • oedema peripheral
  • anhedonia
  • atrial fibrillation
  • fatigue
  • anxiety
  • multiple injuries
  • septic shock
60+:
  • dyspnoea
  • anxiety
  • fall
  • anaemia
  • cardiac failure congestive
  • pain
  • injury
  • dizziness
  • back pain
  • dehydration

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Coumadin and Hydroxyzine pamoate?

Can you answer these questions?

More questions for: Coumadin, Hydroxyzine pamoate

You may be interested in these reviews

More reviews for: Coumadin, Hydroxyzine pamoate

On eHealthMe, Coumadin (warfarin sodium) is often used to treat atrial fibrillation/flutter. Hydroxyzine pamoate (hydroxyzine pamoate) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.